SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001193125-15-081282
Filing Date
2015-03-06
Accepted
2015-03-06 17:25:54
Documents
4

Document Format Files

Seq Description Document Type Size
1 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1 ON FORM S-3 d887100dposam.htm POS AM 430618
2 EXHIBIT 23.1 d887100dex231.htm EX-23.1 1778
3 GRAPHIC g887100g59a96.jpg GRAPHIC 43268
4 GRAPHIC g887100g69v03.jpg GRAPHIC 28662
  Complete submission text file 0001193125-15-081282.txt   532783
Mailing Address 215 FIRST STREET SUITE 400 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 400 CAMBRIDGE MA 02142 617-871-9911
Eleven Biotherapeutics, Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 252025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-201176 | Film No.: 15682666
SIC: 2834 Pharmaceutical Preparations